Competition from heavy hitters spooked investors.
News & Analysis: Quidel
These three stocks have consolidated their strong competitive positions in recent months.
Competition in the Coronavirus Rapid Test Market: What Does it Mean for Quidel and Becton, Dickinson?
With more competition for rapid antigen tests on the way, is Quidel or Becton, Dickinson a better buy?
Rival Abbott is looking to become the dominant player in the coronavirus test arena.
Each of these stocks is up more than 50% this year and should prove resilient in another crash.
Two very different companies with two very promising COVID-19 programs.
Now might be a good time to sell these stocks, before their bubbles burst.
The company's leadership in COVID-19 antigen testing is earning it lot of attention, and more is sure to come.
Distribution of rapid point-of-care diagnostic instruments from Quidel and Becton, Dickinson will begin next week.
Shares of the maker of rapid COVID-19 tests continued their upward movement last month.